Ozempic in Morocco: an innovative drug, but reserved for the wealthiest
After the controversy over its misuse, Ozempic is now at the center of a new debate: access to generics. In Morocco, a five-year exclusivity clause could delay affordable alternatives, effectively turning the treatment into a « medicine for the wealthy. »
The post Ozempic in Morocco: an innovative drug, but reserved for the wealthiest appeared first on Médias24 – Numéro un de l'information économique marocaine.
2025-11-21 17:14:55
medias24.com
